An Official Website of the United States Government
Company Information:
Name:
METALLOPHARM, LLC
Address:
1790 Riverstone Drive
Delaware, OH 43015-
Delaware, OH 43015-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Engineered Synthetic Metallodrugs Directed Against HCV
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Donna T. Palmer
Award Amount:
$256,722.00
Abstract:
DESCRIPTION (provided by applicant): Alcohol is a high risk factor in hepatitis C virus (HCV) infection and increases the severity of the infection. It has been estimated that 35% of alcohol-dependent people carry HCV. HCV is associated with cirrhosis, liv
er failure, and hepatocellular cancer, and… More
Metallodrugs Targeting HCV Protease
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Ada S. Cowan
Award Amount:
$444,050.00
Abstract:
DESCRIPTION (provided by applicant): Alcohol is a high risk factor in hepatitis C virus (HCV) infection and increases the severity of the infection. It has been estimated that 35% of alcohol-dependent people carry HCV. HCV is associated with cirrhosis, liv
er failure, and hepatocellular cancer, and… More
Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Ada S. Cowan – 740-815-9851
Award Amount:
$2,004,496.00
Abstract:
DESCRIPTION (provided by applicant): HCV is responsible for 60% of the cases of chronic hepatitis and 50% of cases of cirrhosis, end- stage liver disease, and liver cancer. An effective vaccine has proved elusive and the preferred therapy with pegylated interferon is effective in less than 50% of… More